Paediatric adverse drug reactions following use of asthma medications in Europe from 2007 to 2011

International Journal of Clinical Pharmacy

Volumn 36, Issue 6, 2014, Pages 1222-1229

  Aagaard, Lise ^a   Hansen, Ebba Holme ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Adverse drug reactions; Asthma; EudraVigilance; Paediatric; Pharmacovigilance; Safety

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; FENOTEROL; FENOTEROL PLUS IPRATROPIUM BROMIDE; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; MOMETASONE FUROATE; MONTELUKAST; SALBUTAMOL; SALMETEROL; TERBUTALINE;

ADRENAL INSUFFICIENCY; ADVERSE DRUG REACTION; AGGRESSION; AGITATION; ANXIETY; ARTICLE; ASTHMA; BENIGN TUMOR; BRADYCARDIA; BRAIN PSEUDOTUMOR; CHEMICAL BURN; CHILD; CONGENITAL DISORDER; COUGHING; CUSHING SYNDROME; DIZZINESS; DRUG FATALITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EAR DISEASE; ELECTROCARDIOGRAPH; ENDOCRINE DISEASE; ERYTHEMA; EYE DISEASE; FEMALE; FEVER; GASTROINTESTINAL DISEASE; GASTROINTESTINAL PAIN; GENETIC DISORDER; GROWTH RETARDATION; HEART DISEASE; HEART PALPITATION; HEMATOLOGIC DISEASE; HEPATOBILIARY DISEASE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTROPHY; HYPOCALCEMIA; HYPOKALEMIA; IMMUNOPATHOLOGY; INFECTION; INFESTATION; INJURY; INNER EAR DISEASE; INTOXICATION; MALE; MENTAL DISEASE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; ORAL BLEEDING; OSTEOPOROSIS; OUTCOME ASSESSMENT; PEDIATRICS; PRIORITY JOURNAL; RASH; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; SKIN DISEASE; TACHYCARDIA; TREMOR; URINARY TRACT DISEASE; VASCULAR DISEASE; VOMITING; ADOLESCENT; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EUROPE; FACTUAL DATABASE; INFANT; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TRENDS;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-ASTHMATIC AGENTS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EUROPE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PHARMACOVIGILANCE; RETROSPECTIVE STUDIES;

EID: 84921937169     PISSN: 22107703     EISSN: 22107711     Source Type: Journal    
DOI: 10.1007/s11096-014-0020-0     Document Type: Article

References (18)

1. Grover C, Armour C, Van Aspersen PP, Moles R, Saini B. Medication use in children with asthma: not a child size problem. J Asthma. 2011;48:1085–103.
2. Thrane N, Sørensen HT. A one-year population-based study of drug prescriptions for Danish children. Acta Paediatr. 1999;88:1131–6.
3. Aagaard L, Hansen EH. Adverse drug reactions associated with asthma medications in children: systematic review of clinical trials. Int J Clin Pharm. 2014;36:243–52.
4. De Vries TW, de Langen-Wouterse JJ, van Puijenbroek E, Duiverman EJ, de Jong-Van den Berg LTW. Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands. Eur J Clin Pharmacol. 2006;62:343–6.
5. de Vries TW, de Langen-Wouterse JJ, de Jong-Van den Berg LTW, Duiverman EJ. Hypertrichosis as a side effect of inhaled steroids in children. Pediatr Pulmonol. 2007;42:370–3.
6. Aagaard L, Hansen EH. Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs. BMC Clin Pharmacol. 2009;9:4. doi:10.1186/1472-6904-9-4.
7. Aagaard L, Christensen A, Hansen EH. Information about adverse drug reactions reported in children: a qualitative review of studies. Br J Clin Pharmacol. 2010;70:481–91.
8. Aagaard L, Hansen EH. Adverse drug reactions in children reported by European consumers from 2007 to 2011. Int J Clin Pharm. 2014;36:295–302.
9. EU directive of the European Parliament and of the Council amending Directive 2001/83/EC as regards information to the general public on medicinal products subject to medical prescription. COM (2012) 48 final. Brussels, 10.2.2012. http://eur-lex.europa.eu/search.html?DTN=0083&or0=DTS%3D3%2CDTS%3D0&qid=1408017970211&type=advanced&DTS_SUBDOM=ALL_ALL&or1=DTT%3DL&SUBDOM_INIT=ALL_ALL&DTS_DOM=ALL&instInvStatus=ALL&DTC=false&DTA=2001&sortOne=TI_SORT&sortOneOrder=desc. Accessed 14 Aug 2014.
10. Hansen EH, Launsø L. Clinical trials: towards a different model. J Pharm Clin. 1987;6:67–74.
11. European Medicines Agency. EudraVigilance access policy for medicines for human use. EMA/759287/2009 corr. Published 23 August 2011. http://www.ema.europa.eu/ema/doc_index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500170699&murl=menus/document_library/document_library.jsp&mid=0b01ac058009a3dc. Accessed 14 Aug 2014.
12. Official Journal of the European communities. Regulation (EC) No. 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access to European Parliament, Council and Commission documents. L 145/43. http://eur-lex.europa.eu/legal-content/DA/ALL/;ELX_SESSIONID=V1qWTskGzb3Hbn0RHNT2yYTtjGnrfzXDTpjbyP1TTrfvK5hG8MkM!-1016850525?uri=CELEX:32001R1049. Accessed 14 Aug 2014.
13. MedDRA. http://www.meddra.org/. Accessed 14 Aug 2014.
14. Volume 9. Pharmacovigilance: medicinal products for human use and veterinary products. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/homev9.htm. Accessed 14 Aug 2014.
15. National Heart Lung and Blood Institute. Guidelines for the diagnosis and management of asthma (EPR-3). http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed 14 Aug 2014.
16. Cereza G, Garcia Doladé N, Laporte JR. Nightmares induced by montelukast in children and adults. Eur Respir J. 2012;40:1574–5.
17. Arellano FM, Arana A, Wentworth CE, Vidaurre CF, Chipps BE. Prescription patterns for asthma medications in children and adolescents with health care insurance in the United States. Pediatr Allergy Immunol. 2011;22:469–76.
18. Pagotto C, Varallo F, Mastroianni P. Strategies to improve adverse drug reaction reporting: a critical and systematic review. Int J Technol Assess Health Care. 2013;29:410–7.